Description

Indication & Scope

QuSai® (Cefotaxime Sodium for Injection) is a prescription third-generation cephalosporin antibiotic indicated for the treatment of susceptible bacterial infections, including lower respiratory tract infections, urinary tract infections, bacterial meningitis, septicemia, intra-abdominal infections, pelvic infections, skin and soft tissue infections, bone and joint infections, and genital tract infections. It is also used for perioperative surgical prophylaxis and is a preferred option for pediatric bacterial meningitis.

Mechanism: Cefotaxime inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), resulting in bacterial cell lysis and death.
Drug class: Third-generation cephalosporin antibiotic.
Clinical use: Treatment of susceptible bacterial infections, bacterial meningitis, septicemia, and perioperative infection prophylaxis.

Specification

Generic Name	Cefotaxime Sodium for Injection
Brand Name	QuSai®
Ingredient	Cefotaxime Sodium
Dosage Form	Injection
Package	0.5 g/vial
Conditions Treated	Respiratory tract infections, urinary tract infections, bacterial meningitis, septicemia, intra-abdominal infections, pelvic infections, skin and soft tissue infections, bone and joint infections
Taboos	Hypersensitivity to cefotaxime, cephalosporins, cephamycins, or other β-lactam antibiotics
Place of origin	China
Prescription type	Prescription Drug (Rx)
Storage Conditions	Store below 20°C in a dry place protected from light. Use immediately after reconstitution whenever possible.
Manufacturer	Shandong Lukang Pharmaceutical Co., Ltd.
Registration Authority	National Medical Products Administration (NMPA), China
Approval Number	H20093362
Approval Date	December 21, 2023
Shelf Life	24 months

How to use ?

Recommended Dose: Adults: 1–2 g by IM injection or IV infusion every 8–12 hours; severe infections may require up to 12 g/day in divided doses.

Time: Administer every 8–12 hours as prescribed.

Instructions for use: Reconstitute before administration. Administer by deep IM injection or slow IV injection/infusion. Do not mix with sodium bicarbonate solutions.

Interaction: Probenecid may increase cefotaxime exposure. Concomitant use with aminoglycosides or loop diuretics may increase nephrotoxicity. Warfarin may increase bleeding risk.

Side effects: Common adverse reactions include injection-site pain, diarrhea, nausea, rash, elevated liver enzymes, eosinophilia, hypersensitivity reactions, and rare severe allergic reactions.

Important Notice

This product should be administered only by qualified healthcare professionals in accordance with the approved prescribing information and local clinical guidelines. Dosage and administration may vary depending on patient condition, indication, and regional regulatory requirements.

Packaging & Shipping

Packaging

Original manufacturer’s packaging with secure export carton. Customized export packaging is available upon request.

Shipping Methods

Express Courier (EMS, DHL, FedEx, UPS), Air Freight, and Sea Freight. Cold-chain transportation is available for products requiring temperature-controlled logistics.

Export Support

Certificate of Analysis

GMP Certificate

Commercial Invoice

Packing List & CPP

Cold Chain Logistics

Customs Documentation

Scientific and regulatory sources

1.WHO References

2.NMPA

3.FDA

4.EMA

FAQ

What is QuSai® Cefotaxime Sodium for Injection used for?

It is used to treat susceptible bacterial infections, including pneumonia, urinary tract infections, bacterial meningitis, septicemia, abdominal infections, and skin infections.

Is cefotaxime suitable for children?

Yes. Cefotaxime is widely used in pediatric patients and is a recommended treatment option for bacterial meningitis in children.

How is cefotaxime administered?

It is administered by intramuscular injection or intravenous injection/infusion under healthcare professional supervision.